Blaise D - Search Results

1

Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host disease.

Stoppa AM, Maraninchi D, Blaise D, Viens P, Hirn M, Olive D, Reiffers J, Milpied N, Gaspard MH, Mawas C. Stoppa AM, et al. Among authors: blaise d. Transpl Int. 1991 Apr;4(1):3-7. doi: 10.1007/BF00335508. Transpl Int. 1991. PMID: 2059297

2

Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse.

Michel G, Gluckman E, Blaise D, Esperou-Bourdeau H, Vernant JP, Kuentz M, Bordigoni P, Milpied N, Rubie H, Thuret I, et al. Michel G, et al. Among authors: blaise d. J Clin Oncol. 1992 Dec;10(12):1865-9. doi: 10.1200/JCO.1992.10.12.1865. J Clin Oncol. 1992. PMID: 1453201

3

Interleukin-2 in association with increasing doses of interferon-gamma in patients with advanced cancer.

Viens P, Blaise D, Stoppa AM, Brandely M, Baume D, Olive D, Resbeut M, Delpero JR, Lopez M, Aubert C, et al. Viens P, et al. Among authors: blaise d. J Immunother (1991). 1992 Apr;11(3):218-24. doi: 10.1097/00002371-199204000-00009. J Immunother (1991). 1992. PMID: 1515426 Clinical Trial.

4

Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infections.

Blaise D, Stoppa AM, Viens P, Sainty D, Fossat C, Miquel M, Olive D, Bouabdallah R, Gabert J, Baume D, et al. Blaise D, et al. Bone Marrow Transplant. 1992 Aug;10(2):193-4. Bone Marrow Transplant. 1992. PMID: 1525610 No abstract available.

5

Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation.

Richard B, Launay-Iliadis MC, Iliadis A, Just-Landi S, Blaise D, Stoppa AM, Viens P, Gaspard MH, Maraninchi D, Cano JP, et al. Richard B, et al. Among authors: blaise d. Br J Cancer. 1992 Mar;65(3):399-404. doi: 10.1038/bjc.1992.81. Br J Cancer. 1992. PMID: 1558794 Free PMC article. Clinical Trial.

6

Phase I trial of recombinant interleukin-2 followed by recombinant tumor necrosis factor in patients with metastatic cancer.

Negrier MS, Pourreau CN, Palmer PA, Ranchere JY, Mercatello A, Viens P, Blaise D, Jasmin C, Misset JL, Franks CR, et al. Negrier MS, et al. Among authors: blaise d. J Immunother (1991). 1992 Feb;11(2):93-102. doi: 10.1097/00002371-199202000-00003. J Immunother (1991). 1992. PMID: 1571336

7

Is allogeneic bone marrow transplantation the best treatment for young adult patients with acute myeloid leukemia in first complete remission. The BGMT Group.

Reiffers J, Stoppa AM, Rigal-Huguet F, Michallet M, Marit G, Blaise D, Attal M, Corront B, Cony-Makhoul P, Gastaut JA, et al. Reiffers J, et al. Among authors: blaise d. Leukemia. 1992;6 Suppl 2:124-6. Leukemia. 1992. PMID: 1578913 No abstract available.

8

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse.

Blaise D, Maraninchi D, Archimbaud E, Reiffers J, Devergie A, Jouet JP, Milpied N, Attal M, Michallet M, Ifrah N, et al. Blaise D, et al. Blood. 1992 May 15;79(10):2578-82. Blood. 1992. PMID: 1586710 Free article. Clinical Trial.

9

Interleukin-2 induces chemotactic deficiency in patients with onco hematologic malignancies and autologous bone marrow transplantation.

Stoppa AM, Fossat C, Blaise D, Viens P, Brandely M, Pourreau CN, Sainty D, Novakovitch G, Miquel M, Juhan-Vague I, et al. Stoppa AM, et al. Among authors: blaise d. Eur Cytokine Netw. 1991 Aug-Sep;2(4):231-7. Eur Cytokine Netw. 1991. PMID: 1661618

10

Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2.

Olive D, Lopez M, Blaise D, Viens P, Stoppa AM, Brandely M, Mawas C, Mannoni P, Maraninchi D. Olive D, et al. Among authors: blaise d. J Immunother (1991). 1991 Dec;10(6):412-7. doi: 10.1097/00002371-199112000-00004. J Immunother (1991). 1991. PMID: 1722705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

767 results

Search Page

Filters